fda compounding semaglutide warning letter news Compounded "semaglutide" is not FDA-approved Compound versions of GLP-1 drugs
Description
Open communication ensures you exhaust appropriate options before making major protocol changes
Moreover, patients with type 1 diabetes who struggle with obesity or insulin resistance may benefit the most
Data Availability: All relevant data are within the paper and its Supporting Information files
Masoumi SJ, Ranjbar S, Keshavarz V
[Dedov II, Shestakova MV, Mayorov AY, et al
Maybe theyll work a little bit but not a whole lot
